JPRN-UMIN000044596已完成未知
The effect of anti-CGRP antibody treatment on migraine aura symptoms - The effect of anti-CGRP antibody treatment on migraine aura symptoms
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with secondary headache except for medication overuse headache 2) Patients with trigeminal autonomic cephalalgias (TACs)
研究者
相似试验
已完成
不适用
The effect of anti-CGRP antibody treatment on central sensitizatiomigraineJPRN-UMIN000044096Tominaga Hospital200
已完成
不适用
The effects of CGRP pathway monoclonal antibody treatment on inner ear function in patients with migraine: a prospective studymigraineJPRN-UMIN000048360Tominaga Hospital25
进行中（未招募）
不适用
Potential Osteocatabolic Effect Caused by Anti-CGRP mAbs in Migraine Patients Treated With Anti-CGRP mAbs - an Observational Pilot Project With Prospectively Collected Health Related DataMigraine DisordersNCT06035458Ente Ospedaliero Cantonale, Bellinzona42
终止
2 期
Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental OxygenCOVID-19 InfectionNCT04346615Pfizer47
已完成
不适用
Prospective multi-center study on pathophysiological features of generalized myasthenia gravis(MG)patients treated with eculizumabGeneralized myasthenia gravisJPRN-jRCTs031190015Murai Hiroyuki41